Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes

por Lebovitz, Harold E.
Publicado 2011

Metabolic Surgery for Type 2 Diabetes with BMI <35 kg/m(2): An Endocrinologist’s Perspective

por Lebovitz, Harold E.
Publicado 2013

Interventional treatment of obesity and diabetes: An interim report on gastric electrical stimulation

por Lebovitz, Harold E.
Publicado 2016

Thiazolidinediones: the Forgotten Diabetes Medications

por Lebovitz, Harold E.
Publicado 2019

Ketosis-Prone Diabetes (Flatbush Diabetes): an Emerging Worldwide Clinically Important Entity

por Lebovitz, Harold E., Banerji, Mary Ann
Publicado 2018

The DIAMOND system in the treatment of type 2 diabetes mellitus in an obese patient

por Kozakowski, Jarosław, Lebovitz, Harold E., Kiciak, Adam, Zgliczyński, Wojciech, Tarnowski, Wiesław
Publicado 2014

Gastric electrical stimulation treatment of type 2 diabetes: effects of implantation versus meal-mediated stimulation. A randomized blinded cross-over trial

por Lebovitz, Harold E, Ludvik, Bernhard, Kozakowski, Jaroslaw, Tarnowski, Wieslaw, Zelewski, Mateusz, Yaniv, Irit, Schwartz, Tse’ela
Publicado 2015

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

por Fouqueray, Pascale, Pirags, Valdis, Inzucchi, Silvio E., Bailey, Clifford J., Schernthaner, Guntram, Diamant, Michaela, Lebovitz, Harold E.
Publicado 2013